ARCHIMED

ARCHIMED is a global investment firm dedicated to the healthcare sector, partnering with scientists, healthcare professionals, entrepreneurs, and investors to support companies in their growth phases through strategic initiatives such as internationalization, innovation, and mergers and acquisitions. The firm specializes in small-cap and mid-cap growth buyout transactions within eight targeted healthcare sectors. With assets under management totaling €7 billion across various funds, ARCHIMED invests between €10 million and €1 billion in leading companies, always backing the corresponding management teams. The firm's portfolio includes companies in biopharmaceutical products, consumer health, healthcare IT, in vitro diagnostics, life science tools and biologic services, medtech, and pharma services. Since its inception, ARCHIMED has been committed to impact investing, both directly and through its EURÊKA Foundation, aiming to advance sustainable global healthcare industries through impactful investments.

Healthcare industry focus, Growth potential, International expansion opportunities, Innovative products or services, Strong management teams, Commitment to impact investing, Companies operating in healthcare industries, Small-cap and mid-cap growth buyout opportunities, Management teams seeking strategic support for growth